SFX by Ex Libris Inc.

Title:	Pyridoxine hydroxamic acids as novel HIV-integrase inhibitors
Source:	Bioorganic & Medicinal Chemistry Letters [0960-894X] Stranix, Brent yr:2016

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Waters, Laura J. "Dolutegravir for treatment of HIV: SPRING forwards?" Lancet (London, England) 381.9868 (2013): 705-706.
description	2.	Morita, M. "Total Syntheses of Perenniporides." Organic letters 17.22 (2015): 5634-5637.
description	3.	Zhao, Z. "Design and discovery of 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide inhibitors of HIV-1 integrase." Bioorganic & medicinal chemistry 22.19 (2014): 5446-5453.
description	4.	Kong, X. "Effective, transition metal free and selective CâF activation under mild conditions." RSC Advances 5.10 (2015): 7035-7048.
description	5.	Castle, Steven L. "Total synthesis of the congested propellane alkaloid (-)-acutumine." Chemical record 14.4 (2014): 580-91.
description	6.	Guo, C. "2,4,5-Trisubstituted thiazole derivatives: A novel and potent class of non-nucleoside inhibitors of wild type and mutant HIV-1 reverse transcriptase." European journal of medicinal chemistry 85 (2014): 27-42.
description	7.	Song, I. "Dolutegravir does not affect methadone pharmacokinetics in opioid-dependent, HIV-seronegative subjects." Drug and alcohol dependence 133.2 (2013): 781-784.
description	8.	Hocqueloux, G. "Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection." The New England journal of medicine 369.19 (2013): 1807-1818.
description	9.	Sharma, H. "Synthesis, docking, and biological studies of phenanthrene Î²-diketo acids as novel HIV-1 integrase inhibitors." Bioorganic and medicinal chemistry letters 23.22 (2013): 6146-6151.
description	10.	Perry, Caroline M. "Dolutegravir: first global approval." Drugs 73.14 (2013): 1627-1637.
description	11.	Leahy, James W. "Discovery of a Novel Series of Potent and Orally Bioavailable Phosphoinositide 3-Kinase gamma Inhibitors." Journal of medicinal chemistry 55.11 (2012): 5467-5482.
description	12.	Johns, Brian A. "Naphthyridinone (NTD) integrase inhibitors:N1 Protio and methyl combination substituent effects with C3 amide groups." Bioorganic and medicinal chemistry letters 23.2 (2013): 422-425.
description	13.	Sugano, Y. "Total Syntheses of (+)-Polygalolide A and (+)-Polygalolide B: Elucidation of the Absolute Stereochemistry and Biogenetic Implications." Chemistry - A European Journal 18.31 (2012): 9682-9690.
description	14.	Garrido, C. "Mechanisms involved in CD4 gains in HIV-infected patients switched to raltegravir." AIDS 26.5 (2012): 551-557.
description	15.	Suzuki, T. "Production of highly optically active (R)-3-chloro-1,2-propanediol using a bacterium assimilating the (S)-isomer." Applied microbiology and biotechnology 40.2 (1993): 273-278.
description	16.	Nakatani, S. "Design and synthesis of quinolinones a! s methionyl - tRNA synthetase inhibitors." Bioorganic & medicinal chemistry 14.21 (2006): 7154-32.
description	17.	Nair, G. "HIV integrase inhibitors as therapeutic agents in AIDS." Reviews in medical virology 17.4 (2007): 277-95.
description	18.	DUDASHJR, J. "Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors." Bioorganic & medicinal chemistry letters 15.21 (2005): 4790-32.
description	19.	CALDERONE, V. "Heterocyclic analogs of benzanilide derivatives as potassium channel activators." European Journal of Medicinal Chemistry 41.6 (2006): 761-767.
description	20.	Walter, M. "Azole derivatives as histamine H3 receptor antagonists, Part 2: C-C and C-S coupled heterocycles." Bioorganic and medicinal chemistry letters 20.19 (2010): 5883-5886.